American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

American Head & Neck Society | AHNS


The mission of the AHNS is to advance Education, Research, and Quality of Care for the head and neck oncology patient.

  • About
    • Mission Statement and Purpose
    • Divisions & Services of the Society
      • Education
        • Scientific Program/Resident Courses
        • Surgical Videos
        • Journal Club
        • Journals
        • Global Outreach
        • Awards
          • Margaret F. Butler Award
      • Diversity, Equity and Inclusion Division
      • Patient Care
        • Cancer Survivorship
          • Patient Education on Post-Treatment Care
          • Interviews with Cancer Survivors
        • Cancer Prevention
          • SLIDE DECK: HPV-Related Oropharyngeal Cancer
        • Guidelines/Position Statements
        • Find-A-Physician
      • Research
        • Grant Information
        • Clinical Trial
        • Tissue Banks
      • Administrative Divison
        • Development Service Process for Evaluating Projects Requiring Funding
    • Leadership
    • History
      • Society Background
      • AHNS History Interviews
      • Past Presidents
      • In Memory
    • AHNS Newsletter
    • Professionalism & Ethics
    • AHNS Policies and Procedures (P&P) Manual
    • AHNS Foundation
    • AHNS Bylaws
    • AHNS Staff
    • AHNS News and Announcements
    • COVID-19 Bulletin Board
  • Heads Up!
  • Post a Job
  • Meetings
    • AHNS Virtual Education Series
      • TORS Webinar Series
    • AHNS Meetings Info
    • AHNS Call For Abstracts
    • AHNS Call For Late Breaking Abstracts
    • Exhibitor and Support Opportunities
    • Past Meetings
    • Related Meetings
  • For Patients
  • For Trainees
    • Accredited Fellowships
      • Fellowship Match
      • Directory of Fellowships
      • Fellowship Curriculum
      • Certificate of Completion Request
      • Fellowship Graduates
      • For Program Directors
      • For Current AHNS Fellows
    • AHNS Surgical Videos
    • Fellows’ Virtual Tumor Boards
    • Cutaneous Cancer
  • Sections
    • Endocrine Surgery
    • Skull Base Surgery Section
    • Reconstructive Head & Neck Surgery
    • Mucosal Malignancy Section
      • Mucosal Malignancy Section Patient Information
    • Salivary Gland
    • Cutaneous Cancer
  • Member Central
    • Join AHNS
    • Find-A-Physician
    • Mailing List Order
  • Log In
  • Donate

Published on June 11, 2020 by AHNS Webmaster

Thomas Ow – Bronx, New York

Practice Contact Information

Montefiore Medical Center/Albert Einstein College of Medicine
3400 Bainbridge Avenue
3rd Floor Medical Arts Pavilion
Bronx
New York
10467
United States

Phone: 718-920-4646
Email:
Web Site:


Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon


Biography/Statement

Dr. Thomas Ow is a head and neck surgeon at Montefiore Medical Center.  He has expertise in the surgical treatment of all head and neck tumors, including mouth and throat cancers, sinus cancers, cancers of the voice box, salivary glands, thyroid and parathyroid glands, and skin cancers in the head and neck regions.  Dr. Ow is also a translational researcher, studying how head and neck cancers grow and spread, and developing biomarkers and new treatments so patients can have better outcomes.

Clinical Trials

Bibliography

Full citation list can be found at:

https://pubmed.ncbi.nlm.nih.gov/?term=Ow%20TJ&sort=date&pos=8

Ow TJ, Spector-Bagdady K, Cowan E, Shuman AG. Broad Consent for Head and Neck Cancer Research. Otolaryngol Head Neck Surg. 2018 May;158(5):835-838. PMID: 29529925.

Tharakan T, Jiang S, Fastenberg J, Ow TJ, Schiff B, Smith RV, Mehta V. Postoperative Pain Control and Opioid Usage Patterns among Patients Undergoing Thyroidectomy and Parathyroidectomy. Otolaryngol Head Neck Surg. 2019 Mar;160(3):394-401. PMID: 30324865

Fattouh M, Chang GY, Ow TJ, Shifteh K, Rosenblatt G, Patel VM, Smith RV, Prystowsky MB, Schlecht NF. Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer. Head Neck. 2019 Mar;41(3):707-714. PMID: 30582237

Mehta V, Ow TJ, Kim S, Tharakan T, Schiff B, Smith RV, In H. Significant racial differences in the incidence and behavior of the follicular variant of papillary thyroid carcinoma. Head Neck. 2019 May;41(5):1403-1411. PMID: 30652370

Ow TJ, Fulcher CD, Thomas C, Broin PÓ, López A, Reyna DE, Smith RV, Sarta C, Prystowsky MB, Schlecht NF, Schiff BA, Rosenblatt G, Belbin TJ, Harris TM, Childs GC, Kawachi N, Guha C, Gavathiotis E. Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1. Oncotarget. 2019 Jan 11;10(4):494-510. PMID: 30728900; PMCID: PMC6355180.

Bresler A, Mehta V, Schiff BA, Smith RV, Khader S, Ramos-Rivera G, Lin J, Libutti SK, Laird AM, Ow TJ. Comparison of Bethesda cytopathology classification to surgical pathology across racial-ethnic groups. Head Neck. 2019 Jul;41(7):2340-2345. PMID: 30793405

Tharakan T, Jiang S, Fastenberg J, Ow TJ, Schiff B, Smith RV, Mehta V. Response to Confounding Factors on the Prediction of Opioid Usage after Thyroidectomy and Parathyroidectomy Surgery. Otolaryngol Head Neck Surg. 2019 Aug;161(2):371-372. PMID: 31369346

Liao DZ, Schlecht NF, Rosenblatt G, Kinkhabwala CM, Leonard JA, Ference RS, Prystowsky MB, Ow TJ, Schiff BA, Smith RV, Mehta V. Association of Delayed Time to Treatment Initiation With Overall Survival and Recurrence Among Patients With Head and Neck Squamous Cell Carcinoma in an Underserved Urban Population. JAMA Otolaryngol Head Neck Surg. 2019 Sep 12. PMID: 31513264

Hochfelder CG, McGinn AP, Mehta V, Castellucci E, Kabarriti R, Ow TJ. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study. Laryngoscope. 2019 Dec 10. PMID: 31821572

Ow TJ, Thomas C, Fulcher CD, Chen J, López A, Reyna DE, Prystowsky MB, Smith RV, Schiff BA, Rosenblatt G, Belbin TJ, Harris TM, Childs GC, Kawachi N, Schlecht NF, Gavathiotis E. Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma. Laryngoscope. 2020 Jan 2. doi: 10.1002/lary.28441. PMID: 31894587

Alli BY, Burk RD, Fatahzadeh M, Grossberg RM, Smith RV, Ow TJ, Wiltz M, Polanco J, Rousseau MC, Nicolau B, Schlecht NF. HIV modifies the effect of tobacco smoking on oral human papillomavirus infection. J Infect Dis. 2020 Mar 25. PMID: 32211783

Shaverdashvili K, Azimi-Neko E, Cohen P, Akbar N, Ow TJ, Halmos B, Castellucci E. INI-1 (SMARCB1) deficient undifferentiated sinonasal carcinoma: novel paradigm of molecular testing in the diagnosis and management of sinonasal malignancies [published online ahead of print, 2020 Apr 26]. Oncologist. 2020;10.1634/theoncologist.2019-0830. doi:10.1634/theoncologist.2019-0830. PMID: 32337786

Views: 305

Share:

  • Facebook
  • Twitter
  • LinkedIn

Related

Contact Us

AHNS, 11300 W. Olympic Blvd, Suite 600
Los Angeles, CA 90064
ph: (310) 437-0559 / fx: (310) 437-0585
[email protected]

Search this website

Follow the AHNS

  • Email
  • Facebook
  • Twitter
  • YouTube

Recent Heads Up! Posts

AHNS 2023 Meeting – Late Breaking Call For Abstracts – 1 Week Left To Submit Abstracts

Registration for the AHNS 2023 is now open!

What’s New on the AHNS Website

More News and Announcements

© 2002–2023 American Head and Neck Society · Privacy and Return Policy
· Managed by BSC Management, Inc